Patients with prostate cancer are known to be affected by higher levels of depression than their peers. Patients with this combination are less likely to undergo definitive treatment and have lower rates of survival. A new study has investigated the likelihood of a diagnosis of depression prior to prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Prasad, S. M. et al. Effect of depression on diagnosis, treatment and mortality of men with clinically localized prostate cancer. J. Clin. Oncol. 32, 2471–2478 (2014).
Sharpley, C. F., Bitsika, V. & Christie, D. R. H. Psychological distress among prostate cancer patients: Fact or fiction. Clin. Med. Oncol. 2, 563–572 (2008).
Reiche, E. M. V., Nunes, S. O. V. & Morimoto, H. K. Stress, depression, the immune system, and cancer. Lancet Oncol. 5, 617–625 (2004).
Kiecolt, J. K., Robles, T. F., Heffner, K. L. & Glaser, R. Psycho-oncology and cancer: psychoneuroimmunology and cancer. Ann. Oncol. 13, 165–169 (2002).
Di Matteo, R. M., Lepper, H. S. & Croghan, T. W. Depression is a risk factor for non-compliance with medical treatment.: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160, 2101–2107 (2000).
Pinquart, M. & Duberstein, P. R. Depression and cancer mortality: a meta-analysis. Psychol. Med. 40, 11, 1797–1810 (2010).
Sharpley, C. F., Bitsika, V. & Christie, D. R. H. Do prostate cancer patients suffer more from depressed mood or anhedonia? Psycho-Oncol. 22, 1718–1723 (2013).
Berry, D. L. et al. Factors that predict treatment choice and satisfaction with the decisions in men with localized prostate cancer. Clin. Genitourin. Cancer 5, 219–226 (2006).
Sharpley, C. F., Christie, D. R. H. & Bitsika, V. Do hormone treatments for prostate cancer cause anxiety and depression? Int. J. Clin. Oncol. 19, 523–530 (2014).
Sharpley, C. F., Bitsika, V. & Christie, D. R. H. Do patient-reported androgen deprivation therapy side effects predict anxiety and depression among prostate cancer patients undergoing radiotherapy? Implications for psychosocial therapy interventions. J. Psychosoc. Oncol. 30, 185–197 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Christie, D., Sharpley, C. Depression and prostate cancer—why do they show up together?. Nat Rev Urol 11, 547–548 (2014). https://doi.org/10.1038/nrurol.2014.226
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2014.226
This article is cited by
-
Depression and prostate cancer: implications for urologists and oncologists
Nature Reviews Urology (2020)